News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
761,609 Results
Type
Article (67049)
Company Profile (218)
Press Release (694324)
Multimedia
Podcasts (184)
Webinars (29)
Section
Business (206255)
Career Advice (3434)
Deals (36027)
Drug Delivery (152)
Drug Development (84654)
Employer Resources (194)
FDA (17896)
Job Trends (16259)
News (357294)
Policy (37019)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2959)
Academic (2)
Accelerated approval (40)
Adcomms (35)
Allergies (161)
Alliances (53330)
ALS (190)
Alzheimer's disease (1804)
Antibody-drug conjugate (ADC) (360)
Approvals (18098)
Artificial intelligence (627)
Autoimmune disease (184)
Automation (47)
Bankruptcy (375)
Best Places to Work (12140)
BIOSECURE Act (23)
Biosimilars (212)
Biotechnology (137)
Bladder cancer (168)
Brain cancer (68)
Breast cancer (680)
Cancer (5228)
Cardiovascular disease (465)
Career advice (2931)
Career pathing (43)
CAR-T (314)
CDC (67)
Celiac Disease (2)
Cell therapy (845)
Cervical cancer (38)
Clinical research (72061)
Collaboration (1906)
Company closure (5)
Compensation (847)
Complete response letters (79)
COVID-19 (2966)
CRISPR (105)
C-suite (946)
Cystic fibrosis (152)
Data (6561)
Decentralized trials (2)
Denatured (59)
Depression (158)
Diabetes (543)
Diagnostics (7115)
Digital health (50)
Diversity (10)
Diversity, equity & inclusion (47)
Drug discovery (299)
Drug pricing (229)
Drug shortages (36)
Duchenne muscular dystrophy (256)
Earnings (85426)
Editorial (69)
Employer branding (23)
Employer resources (168)
Events (111394)
Executive appointments (1054)
FDA (21212)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (25)
Funding (1597)
Gene editing (223)
Generative AI (64)
Gene therapy (701)
GLP-1 (1136)
Government (5290)
Grass and pollen (8)
Guidances (388)
Healthcare (19850)
HIV (74)
Huntington's disease (51)
IgA nephropathy (88)
Immunology and inflammation (303)
Immuno-oncology (74)
Indications (128)
Infectious disease (3282)
Inflammatory bowel disease (215)
Inflation Reduction Act (17)
Influenza (134)
Intellectual property (263)
Interviews (663)
IPO (16471)
IRA (60)
Job creations (4446)
Job search strategy (2386)
JPM (73)
Kidney cancer (19)
Labor market (92)
Layoffs (653)
Leadership (44)
Legal (9345)
Liver cancer (100)
Longevity (19)
Lung cancer (708)
Lymphoma (394)
Machine learning (48)
Management (64)
Manufacturing (897)
MASH (180)
Medical device (14198)
Medtech (14258)
Mergers & acquisitions (20645)
Metabolic disorders (1436)
mRNA (193)
Multiple sclerosis (175)
NASH (23)
Neurodegenerative disease (377)
Neuropsychiatric disorders (107)
Neuroscience (3196)
Neurotech (1)
NextGen: Class of 2026 (7142)
Non-profit (5037)
Now hiring (56)
Obesity (698)
Opinion (344)
Ovarian cancer (169)
Pain (226)
Pancreatic cancer (247)
Parkinson's disease (313)
Partnered (37)
Patents (536)
Patient recruitment (540)
Peanut (64)
People (60298)
Pharmaceutical (52)
Pharmacy benefit managers (33)
Phase 1 (22171)
Phase 2 (31398)
Phase 3 (24049)
Pipeline (5919)
Policy (350)
Postmarket research (2926)
Preclinical (9586)
Press Release (71)
Prostate cancer (269)
Psychedelics (60)
Radiopharmaceuticals (299)
Rare diseases (983)
Real estate (6586)
Recruiting (79)
Regulatory (27301)
Reports (58)
Research institute (2703)
Resumes & cover letters (532)
Rett syndrome (30)
RNA editing (20)
RSV (90)
Schizophrenia (165)
Series A (269)
Series B (202)
Service/supplier (10)
Sickle cell disease (108)
Special edition (29)
Spinal muscular atrophy (174)
Sponsored (49)
Startups (3887)
State (2)
Stomach cancer (21)
Supply chain (116)
Tariffs (101)
The Weekly (123)
Vaccines (1168)
Venture capital (99)
Weight loss (478)
Women's health (101)
Worklife (23)
Date
Last 7 days (884)
Last 30 days (2775)
Last 365 days (30872)
2026 (5044)
2025 (31238)
2024 (35702)
2023 (40298)
2022 (51390)
2021 (56013)
2020 (55317)
2019 (49218)
2018 (37485)
2017 (34936)
2016 (34627)
2015 (39812)
2014 (33839)
2013 (30171)
2012 (30838)
2011 (31115)
2010 (29549)
Location
Africa (1087)
Alabama (93)
Alaska (7)
Arizona (290)
Arkansas (15)
Asia (46306)
Australia (7883)
California (11256)
Canada (3376)
China (1206)
Colorado (498)
Connecticut (497)
Delaware (323)
Europe (104722)
Florida (1774)
Georgia (380)
Hawaii (3)
Idaho (64)
Illinois (948)
India (77)
Indiana (546)
Iowa (22)
Japan (458)
Kansas (128)
Kentucky (45)
Louisiana (30)
Maine (84)
Maryland (1417)
Massachusetts (8085)
Michigan (367)
Minnesota (605)
Mississippi (7)
Missouri (142)
Montana (36)
Nebraska (30)
Nevada (132)
New Hampshire (88)
New Jersey (3162)
New Mexico (31)
New York (3044)
North Carolina (1521)
North Dakota (10)
Northern California (5466)
Ohio (359)
Oklahoma (22)
Oregon (44)
Pennsylvania (2295)
Puerto Rico (25)
Rhode Island (49)
South America (1461)
South Carolina (70)
South Dakota (1)
Southern California (4409)
Tennessee (179)
Texas (1788)
United States (40801)
Utah (366)
Vermont (1)
Virginia (285)
Washington D.C. (84)
Washington State (930)
West Virginia (4)
Wisconsin (116)
Wyoming (2)
761,609 Results for "la jolla institute for allergy and immunology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
La Jolla Institute for Immunology and RevolKa started a Research Collaboration
RevolKa Ltd., a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology agreed to start a research collaboration to create antigens for the next-generation vaccines to deliver innovative solutions to unmet medical need in infectious diseases.
April 18, 2024
·
2 min read
Press Releases
Regeneron Highlights Expanding Immunology Portfolio and Pipeline at AAAAI, Showcasing Novel Approaches to Treating Allergy
February 10, 2026
·
25 min read
Press Releases
KalVista Pharmaceuticals to Present EKTERLY® (sebetralstat) Data at the 2026 American Academy of Allergy, Asthma & Immunology Annual Meeting
February 12, 2026
·
4 min read
Press Releases
BioCryst to Present New HAE Data from ORLADEYO® (berotralstat) and Navenibart at the 2026 American Academy of Allergy, Asthma & Immunology Annual Meeting
February 11, 2026
·
8 min read
Press Releases
ARS Pharmaceuticals to Showcase Scientific Innovation and Robust Clinical Data on neffy® (epinephrine nasal spray) at 2026 American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Scientific Meeting
February 10, 2026
·
11 min read
Press Releases
The future of allergy treatment
February 24, 2026
·
1 min read
Press Releases
Astria Therapeutics to Present at Upcoming American College of Allergy, Asthma, and Immunology Annual Scientific Meeting
October 31, 2025
·
1 min read
Press Releases
KalVista Pharmaceuticals to Present New EKTERLY® (sebetralstat) Data at the American College of Allergy, Asthma & Immunology 2025 Annual Scientific Meeting
October 31, 2025
·
4 min read
Press Releases
Shattuck Labs Announces Participation in Upcoming Piper Sandler Virtual Novel Targets in Immunology Symposium
February 8, 2026
·
2 min read
Press Releases
ARS Pharma to Present Real-World Data on Intranasal Epinephrine at 2025 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting
November 4, 2025
·
12 min read
1 of 76,161
Next
